tirzepatide pregnancy recommendations and Pregnancy: Safety, Risks, and Clinical Guidance Understanding GLP-1 Medications and Pregnancy

Never share pens or needles with others, even if you change the needle

The best choice depends on your tolerance, medical needs, and healthcare providers guidance

Like any prescription medication, weight loss medications by Hims may cause side effects in some people

On the medical front, new medications and minimally invasive procedures are being developed and refined, providing additional tools for healthcare providers to help patients achieve their weight loss goals

Mounjaro tirzepatide injection, solution [prescribing information]

Earlier this week, Citi cut its price target on Hims & Hers to $16.50 from $30 and maintained a Sell rating, warning that the companys GLP-1 strategy was risky and aggressive. Citi said its target reflects a 25% probability of Hims losing all weight-loss drug sales, a 60% base-case scenario of losing half of those sales, and only a 15% bull-case outcome with limited GLP-1 downside